Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hepatitis infection in immunocompromised patients

¹Division of Digestive Diseases, UCLA School of Medicine.

Gastroenterology Clinics of North America

|September 1, 1994

Summary

The long-term effects of hepatitis in immunocompromised patients remain unclear due to the disease

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Alginate microbead release assay of angiogenesis.

Methods in molecular medicine·2011

Same author

Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing.

Artificial organs·2001

Same author

Hepatitis C screening strategies in hemodialysis patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001

Same author

Automated RIBA HCV strip immunoblot assay: a novel tool for the diagnosis of hepatitis C virus infection in hemodialysis patients.

American journal of nephrology·2001

Same author

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.

Hepatology (Baltimore, Md.)·2001

Same author

Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001

Area of Science:

Hepatology
Immunology

Background:

The long-term prognosis of hepatitis infection in immunocompromised individuals is not well-established.
Hepatitis progression is typically slow, complicating long-term outcome assessments.

Purpose of the Study:

To review the current literature regarding the long-term course of hepatitis in immunocompromised patients.
To identify gaps in knowledge concerning immunosuppression's impact on hepatitis progression.

Main Methods:

Literature review of existing studies on hepatitis in immunocompromised patients.
Analysis of documented incidence rates of chronic active hepatitis and cirrhosis.

Main Results:

Current literature lacks sufficient prospective, long-term studies.
Available evidence does not conclusively show that immunosuppression accelerates hepatitis progression.
Some studies indicate a low incidence of severe outcomes like cirrhosis in this population.

Conclusions:

Reliable conclusions regarding hepatitis' long-term course in immunocompromised patients cannot be drawn due to insufficient high-quality research.
Further well-designed, long-term prospective studies are needed to clarify the impact of immunosuppression on hepatitis outcomes.

Related Experiment Videos